WHO Guideline Advises Against Fluvoxamine, Colchicine for COVID-19
FRIDAY, July 15, 2022 -- Fluvoxamine and colchicine are not recommended for nonsevere COVID-19, according to the 11th version of the World Health Organization living guideline on drugs for COVID-19 published online July 13 in The BMJ.
Arnav Agarwal,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Colchicine | Colcrys | COVID-19 | International Medicine & Public Health | Pharmaceuticals | WHO